Hafnium oxide nanoparticles NBTXR3 activated by radiotherapy as a new therapeutic option for elderly/frail HNSCC patients.

Christophe Le Tourneau,Victor Moreno,Sébastien Salas,Xavier Mirabel,Emiliano Calvo,Bernard Doger,C. Florescu,Juliette Thariat,Jacek Fijuth,Tomasz Rutkowski,Nicolas Magné,X. Liem,Nicolas Fakhry,Stéphanie Wong Hee Kam,Valentin Calugaru,Caroline Hoffmann

Hafnium oxide nanoparticles NBTXR3 activated by radiotherapy as a new therapeutic option for elderly/frail HNSCC patients.

2019

Christophe Le Tourneau
Victor Moreno
Sébastien Salas
Xavier Mirabel
Emiliano Calvo
Bernard Doger
C. Florescu
Juliette Thariat
Jacek Fijuth
Tomasz Rutkowski
Nicolas Magné
X. Liem
Nicolas Fakhry
Stéphanie Wong Hee Kam
Valentin Calugaru
Caroline Hoffmann

6069Background: New therapeutic approaches are needed for elderly or frail head and neck squamous cell carcinoma (HNSCC) patients (pts) ineligible for standard of care treatment. NBTXR3, a crystall...

Keywords:

Physical therapy
Elderly frail
Oncology
Radiation therapy
Hafnium oxide
Internal medicine
Medicine
Head and neck squamous-cell carcinoma
standard of care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations